Key Takeaways
- Invaio Sciences named Magalie Guilhabert, Ph.D., as Chief Science Officer, effective immediately.
- Guilhabert joins from Ginkgo Bioworks, where she led R&D and Operations for the Agriculture Business Unit.
- She brings over 20 years of experience in biological innovation, previously holding leadership roles at Bayer and AgraQuest.
- Invaio’s leadership highlighted Guilhabert’s expertise in aligning scientific innovation with commercial impact.
- The appointment reinforces Invaio’s commitment to advancing nature-positive, sustainable agricultural technologies.
Invaio Sciences strengthens leadership with new Chief Science Officer
Invaio Sciences, a Flagship Pioneering-founded bioplatform company, announced the appointment of Magalie Guilhabert, Ph.D., as Chief Science Officer. Guilhabert brings two decades of scientific and operational leadership experience aimed at transforming innovative research into practical, sustainable solutions for agriculture.
Amy O’Shea, CEO of Invaio Sciences and CEO-Partner of Flagship Pioneering, welcomed the appointment, stating:
“Her extensive experience in building high-performing teams and delivering groundbreaking biological solutions aligns perfectly with our mission to revolutionize crop health and agriculture sustainability.”
Proven track record in agricultural innovation
Guilhabert joins Invaio Sciences from Ginkgo Bioworks, where she served as Vice President and Head of Research & Development and Operations for the Agriculture Business Unit. There, she successfully transformed the department into a fully integrated unit managing 100 scientists and a $41 million revenue target. Her leadership advanced synthetic biology and microbial genetics, contributing to the development of innovative agricultural products.
Before her tenure at Ginkgo, Guilhabert held key leadership roles at Bayer US LLC, including Vice President and Global Head of Microbial Research Technologies Biologics. At Bayer, she directed a team of 70 scientists and helped build a microbial-based active ingredient pipeline aimed at a market potential exceeding $1 billion.
Guilhabert holds a Ph.D. in Plant Pathology from the University of California, Davis, and advanced degrees from French institutions. She is also an active contributor to the scientific community, with 15 patents and a board position at the International Alliance for Phytobiome Research.
Advancing Invaio’s mission for sustainable agriculture
In her new role, Guilhabert will oversee Invaio Sciences’ global research and development strategy, focusing on delivering innovative, environmentally sustainable crop protection technologies.
“This is a pivotal moment in agriculture and I look forward to contributing to Invaio’s scientific strategy,” said Guilhabert.
“The company’s focus on biological innovation resonates deeply with my passion for creating sustainable, customer-focused solutions.”
With Guilhabert’s appointment, Invaio Sciences reaffirms its commitment to advancing nature-positive technologies and supporting farmers in adopting sustainable solutions that benefit both productivity and environmental health.
